The Third Extension of Telehealth Flexibilities—Implications and Limitations
In Novemer, 2024, the DEA announced its third temporary extension of telehealth flexibilities for prescribing controlled medications. What does this mean for the future?
Cynthia Jimes is a social scientist with a background in organizational learning. She has nearly two decades of experience leading research and applied projects in the healthcare, technology and education sectors. Cynthia holds a Ph.D. in Information Science from Sweden’s Uppsala University.
As the Director of Research at Workit Health, Marlene Lira is focused on research dissemination, developing research partnerships, and informing clinical care with the latest evidence-based developments in substance use treatment. Marlene received her MPH in epidemiology from the Harvard T.H. Chan School of Public Health and is pursuing her DrPH in health policy at the Johns Hopkins Bloomberg School of Public Health. Her research spans clinical and policy aspects of substance use and has been featured in the New York Times. Marlene is the president-elect of the New Mexico Society for Addiction Medicine.
In Novemer, 2024, the DEA announced its third temporary extension of telehealth flexibilities for prescribing controlled medications. What does this mean for the future?
© 2024 Workit Health. All rights reserved. | Terms of Service | Privacy Policy | HIPAA Notice
This site uses cookies to improve your experience. By using this site, you consent to our use of cookies.